drugset / Trial / NCT00314613

Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

NCT00314613

Phase 4 Terminated 30 enrolled Duke University Janssen, LP · collab
Non-randomizedOpen-labelTreatment

Summary

Assured treatment with Risperal CONSTA will provide first-episode patients, who have a greater potential for therapeutic response, with their best opportunity for continued improvement in cognitive function beyond three months of treatment.

Timeline

Start
2006-04
Primary completion
2006-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified

Indications